{"id":"https://openalex.org/W2106580292","doi":null,"title":"Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.","display_name":"Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.","publication_year":1986,"publication_date":"1986-07-01","ids":{"openalex":"https://openalex.org/W2106580292","mag":"2106580292","pmid":"https://pubmed.ncbi.nlm.nih.gov/3754787"},"language":"en","primary_location":{"id":"pmid:3754787","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3754787","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006242958","display_name":"Marcel Odaimi","orcid":"https://orcid.org/0009-0002-6021-0360","observed_orcids":["https://orcid.org/0009-0002-6021-0360","https://orcid.org/0000-0002-3244-1957"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Odaimi","raw_affiliation_strings":["University of Texas Health Science Center at Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center at Houston","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004417292","display_name":"B\u00f6rje S. Andersson","orcid":"https://orcid.org/0000-0003-4761-0220","observed_orcids":["https://orcid.org/0000-0003-4761-0220"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B S Andersson","raw_affiliation_strings":["Stem Cell Transplantation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111673665","display_name":"Kenneth B. McCredie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K B McCredie","raw_affiliation_strings":["University of Texas Health Science Center at Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center at Houston","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030171128","display_name":"Miloslav Beran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Beran","raw_affiliation_strings":["University of Texas Health Science Center at Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Health Science Center at Houston","institution_ids":["https://openalex.org/I919571938"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0517,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.91515201,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"46","issue":"7","first_page":"3330","last_page":"3"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8838000297546387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8838000297546387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.040800001472234726,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.028300000354647636,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/4-9-acridinylamino-methanesulfon-m-anisidide","display_name":"4'-(9-acridinylamino)methanesulfon-m-anisidide","score":0.9490000009536743},{"id":"https://openalex.org/keywords/anthracycline-resistance","display_name":"anthracycline resistance","score":0.6389999985694885},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.9039999842643738},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8090000152587891},{"id":"https://openalex.org/keywords/aclacinomycin","display_name":"aclacinomycin","score":0.8220000267028809},{"id":"https://openalex.org/keywords/vinca-alkaloids","display_name":"vinca alkaloids","score":0.9120000004768372},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.9990000128746033},{"id":"https://openalex.org/keywords/1-beta-d-arabinofuranosylcytosine","display_name":"1-beta-D-arabinofuranosylcytosine","score":0.9380000233650208},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.4429999887943268},{"id":"https://openalex.org/keywords/clonogenic-assay","display_name":"clonogenic assay","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C2780500152","wikidata":"https://www.wikidata.org/wiki/Q2784004","display_name":"Amsacrine","level":4,"score":0.79926598072052},{"id":"https://openalex.org/C2778080818","wikidata":"https://www.wikidata.org/wiki/Q1788422","display_name":"Cross-resistance","level":2,"score":0.6880268454551697},{"id":"https://openalex.org/C2777096885","wikidata":"https://www.wikidata.org/wiki/Q220925","display_name":"Vinca","level":2,"score":0.6492490172386169},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6298624277114868},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.5831859707832336},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5676894783973694},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5545576214790344},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4512341618537903},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.43424057960510254},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.42252999544143677},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4137575030326843},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40441465377807617},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3367788791656494},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3166566789150238},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2351701259613037},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2081679105758667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1677124798297882},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.14231809973716736}],"mesh":[{"descriptor_ui":"D000609","descriptor_name":"Aminoacridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000677","descriptor_name":"Amsacrine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:3754787","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3754787","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2106580292","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3754787","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8999999761581421,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1514525963","https://openalex.org/W1792416141","https://openalex.org/W2013040611","https://openalex.org/W2082720191","https://openalex.org/W2120220515","https://openalex.org/W2149883422","https://openalex.org/W2408993012","https://openalex.org/W2417050935","https://openalex.org/W2418433777","https://openalex.org/W2469826906"],"related_works":["https://openalex.org/W2082720191","https://openalex.org/W1603345015","https://openalex.org/W2408993012","https://openalex.org/W1532947306","https://openalex.org/W2406153402","https://openalex.org/W7100131827","https://openalex.org/W2113851207","https://openalex.org/W2045853679","https://openalex.org/W2767969168","https://openalex.org/W2079032862"],"abstract_inverted_index":{"A":[0],"subline":[1,65,112],"of":[2,29,39,41,48],"the":[3,27,30,52,63,70,96],"HL-60":[4],"leukemia":[5],"resistant":[6,64],"to":[7,19,57,69,74,83,95,107,115],"4'-(9-acridinylamino)methanesulfon-m-anisidide":[8,20],"(HL-60/AMSA)":[9],"was":[10,43,60,92,109,113],"developed":[11],"by":[12],"intermittent":[13],"long-term":[14],"in":[15,26,62],"vitro":[16],"treatment.":[17],"Resistance":[18],"remained":[21],"unchanged":[22],"after":[23],"180":[24],"doublings":[25],"absence":[28],"drug,":[31],"suggesting":[32],"a":[33,46],"stable":[34],"phenotypic":[35],"alteration.":[36],"The":[37,111],"pattern":[38],"cross-resistance":[40,56],"HL-60/AMSA":[42,78,91],"evaluated":[44],"for":[45,72,88],"spectrum":[47],"antileukemic":[49],"agents":[50],"using":[51],"clonogenic":[53],"assay.":[54],"Modest":[55],"doxorubicin":[58,84],"(Adriamycin)":[59],"observed":[61],"on":[66],"continuous":[67],"exposure":[68,87],"drug":[71],"8":[73],"9":[75],"days;":[76],"however,":[77],"cells":[79],"retained":[80],"their":[81],"sensitivity":[82,106],"following":[85],"short-term":[86],"60":[89],"min.":[90],"also":[93],"sensitive":[94],"anthracycline":[97],"aclacinomycin,":[98],"Vinca":[99],"alkaloids,":[100],"and":[101],"alkylating":[102],"agents.":[103],"Furthermore,":[104],"enhanced":[105],"1-beta-D-arabinofuranosylcytosine":[108],"observed.":[110],"cross-resistant":[114],"etoposide.":[116]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}